Nuclera CEO Michael Chen next to one of the eProtein Discovery boxes (Credit: Nuclera)

October 15, 2024 04:00 AM EDTUpdated 06:20 AM

Exclusive: Biotech tools company raises $75M for protein manufacturing tech

Anna Brown

News Reporter

Protein production company Nuclera has raised a $75 million Series C to continue to bring its manufacturing platform to market next January after a soft …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Biotech tools company raises $75M for protein manufacturing tech

Anna Brown

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Two GSK trials with long-acting drug in chronic rhinosinusitis hit primary endpoints

Eli Lilly reveals £279M investment in the UK through new government deal

Pfizer details results from failed Phase 3 trial of Duchenne muscular dystrophy gene therapy

Novo Nordisk files 18 lawsuits against GLP-1 compounders in 44 days

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Biotech tools company raises $75M for protein manufacturing tech